Articles From: Monster Beverage Reports 2014 Third Quarter Financial Results to PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat) Capsules for $65.6 Million


CORONA, Calif., Nov.
Sign-up for Monster Beverage Reports 2014 Third Quarter Financial Results investment picks
Total revenues of $25.6 million, up 38% year-over-year NEW YORK, Nov.
Sign-up for Varonis Announces Third Quarter 2014 Financial Results investment picks
MENLO PARK, Calif., Nov.
Sign-up for Versartis Reports Third Quarter 2014 Financial Results investment picks
2014/11/6
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended September 30, 2014.
Sign-up for Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year investment picks
http://media.marketwire.com/attachments/201410/281332_ARC-Linear-Lockup-JPG300pxwide.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157033&ProfileId=051205&sourceType=1 WALNUT CREEK, CA --
Sign-up for ARC Document Solutions Reports Results for Third Quarter 2014 investment picks
NEW YORK, Nov.
Sign-up for Fairway Group Holdings Corp. Reports Second Quarter Results investment picks
FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or FX, trading and related services, today announced for the quarter ended September 30, 2014, U.S. GAAP revenues of $116.1 million, compared to $113.2 million for the quarter ended September 30, 2013, an increase of 3%. U.S. GAAP net income attributable to FXCM Inc. was $2.4 million for the Third Quarter 2014 or $0.05 per diluted share, compared to U.S. GAAP net loss of $5.1 million or $0.15 per diluted share for the Third Quarter 2013.
Sign-up for FXCM Inc. Announces Third Quarter 2014 Results investment picks
Rovi Corporation (NASDAQ:ROVI) today reported financial results for the third quarter ended September 30, 2014.
Sign-up for Rovi Corporation Reports Third Quarter 2014 Financial Results investment picks
Salix Pharmaceuticals, Ltd.
Sign-up for Salix Pharmaceuticals Reports 3Q2014 Results investment picks
DELIVERS $175M IN BOOKINGS AND $2M IN ADJUSTED EBITDA ZYNGA REAFFIRMS FULL YEAR 2014 OUTLOOK FOR BOOKINGS AND ADJUSTED EBITDA SAN FRANCISCO, Nov.
Sign-up for Zynga Announces Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/200810/472497_Salemlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156826&ProfileId=051205&sourceType=1 CAMARILLO, CA --
Sign-up for Salem Announces 19% Increase in Net Revenue for the Third Quarter 2014 investment picks
LOS ANGELES, Nov.
Sign-up for Global Eagle Entertainment Promotes Michael Zemetra to Chief Financial Officer investment picks
Revenues Increase 19% from Second Quarter of 2014 SAN DIEGO, Nov.
Sign-up for Novatel Wireless Reports Third Quarter 2014 Financial Results investment picks
SAN DIEGO, Nov.
Sign-up for Novatel Wireless Announces New Credit Facility investment picks
The Board of Directors of Bemis Company, Inc. (NYSE:BMS) has declared a regular quarterly dividend of 27 cents per share.
Sign-up for Bemis Company Declares Regular Quarterly Dividend investment picks
2014/11/6
Air Lease Corporation (NYSE: AL) (the “Company” or “ALC”) today announced that a wholly-owned subsidiary of the Company entered into a joint venture with a co-investment vehicle (the “JV Partner”) arranged by Napier Park Global Capital (US) LP (“Napier Park”) for the purpose of investing in commercial aircraft and leasing them to airlines around the globe.
Sign-up for Air Lease Corporation Partners in a New Aircraft Leasing Joint Venture, Blackbird Capital I, to Acquire up to $2 Billion in Aircraft investment picks
PROS Holdings, Inc. (NYSE: PRO), a big data software company, today announced financial results for the third quarter ended September 30, 2014.
Sign-up for PROS Holdings, Inc. Reports Third Quarter 2014 Financial Results investment picks
Rexnord Corporation (NYSE:RXN): Second Quarter Highlights Net sales were $538 million --
Sign-up for Rexnord Corporation Second Quarter Fiscal 2015 Results investment picks
TORONTO, Nov.
Sign-up for NOVADAQ Reports Third Quarter 2014 Financial Results investment picks
- Revenue increased 11 percent to $922 million - Diluted earnings per share (EPS) from continuing operations totaled $0.37 on a GAAP basis and increased 14 percent from the prior year period to $0.50 per adjusted share - Company increases fiscal 2015 adjusted diluted EPS guidance range to $2.80 to $2.95, driven primarily by a second quarter tax settlement with the Internal Revenue Service SAN DIEGO , Nov.
Sign-up for CareFusion Reports First Quarter Fiscal 2015 Results investment picks
Fourth Quarter Results Include: - Net Sales of $303.3 Million, Up 3.8 Percent Sequentially and 21.1 Percent Over Prior Year - Gross Margin of 56.4 Percent - GAAP Diluted Earnings per Share of $0.34 - Non-GAAP Diluted Earnings per Share of $0.64 - Operating Cash Flow of $59.6 Million ALISO VIEJO, Calif.
Sign-up for Microsemi Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
Financial Engines (NASDAQ:FNGN), America’s largest independent registered investment advisor 1 , today announced the appointment of Lawrence M.
Sign-up for Financial Engines Announces CEO Succession investment picks
Willdan Group, Inc. (“Willdan”) (NASDAQ: WLDN), a provider of professional technical and consulting services, today reported financial results for its third quarter ended September 26, 2014, and provided a business update.
Sign-up for Willdan Group Reports Third Quarter 2014 Financial Results investment picks
2014/11/6
ANNAPOLIS, Md.
Sign-up for PharmAthene Provides Third Quarter 2014 Operational And Financial Update investment picks
-- Non-Candy Crush titles generated $264 million, or 49% of total gross bookings in third quarter 2014, an increase of 167% year over year and up from 15% of gross bookings in third quarter 2013 --
Sign-up for King Reports Third Quarter 2014 Results, Announces $150 Million Share Repurchase Program investment picks
First Quarter Operating Income Grew 53% to $7.8M SALT LAKE CITY, Nov.
Sign-up for LifeVantage Announces First Quarter Fiscal Year 2015 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Monster Beverage Reports 2014 Third Quarter Financial Results to PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat) Capsules for $65.6 Million
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent